Skip to main content
Sirona Biochem Corp. logo

Sirona Biochem Corp. — Investor Relations & Filings

Ticker · SRBCF ISIN · CA82967M1005 LEI · 549300CQE1Q87IG6W210 TSXV Real estate activities
Filings indexed 367 across all filing types
Latest filing 2017-04-20 Regulatory Filings
Country CA Canada
Listing TSXV SRBCF

About Sirona Biochem Corp.

https://www.sironabiochem.com/

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery firm utilizing a proprietary platform technology to develop novel compounds. Through its wholly-owned French subsidiary, TFChem, the company specializes in stabilizing carbohydrate molecules, often via fluorination chemistry, to enhance their efficacy and safety for medical and cosmetic applications. Sirona Biochem's business strategy involves licensing or selling its patented compounds, such as the anti-aging and anti-wrinkle molecule GlycoProteMim™ (TFC-1326), to leading global pharmaceutical and cosmetic companies in exchange for up-front fees, milestone payments, and ongoing royalties.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings
2017-04-20 English
News release - English.pdf
Regulatory Filings
2017-04-05 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings
2017-03-30 English
Interim MD&A - English.pdf
Regulatory Filings
2017-03-30 English
Interim financial statements/report – English.pdf
Regulatory Filings
2017-03-30 English
Annual MD&A - English.pdf
Regulatory Filings
2017-03-01 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.